关注
Yao Tong
Yao Tong
在 wisc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
NAD (H)-loaded nanoparticles for efficient sepsis therapy via modulating immune and vascular homeostasis
M Ye, Y Zhao, Y Wang, R Xie, Y Tong, JD Sauer, S Gong
Nature nanotechnology 17 (8), 880-890, 2022
832022
A selective fluorescent turn-on probe for imaging peroxynitrite in living cells and drug-damaged liver tissues
L Xia, Y Tong, L Li, M Cui, Y Gu, P Wang
Talanta 204, 431-437, 2019
452019
Overcoming the Blood–Brain Barrier for Gene Therapy via Systemic Administration of GSH‐Responsive Silica Nanocapsules
Y Wang, X Wang, R Xie, JC Burger, Y Tong, S Gong
Advanced Materials 35 (6), 2208018, 2023
432023
Multimodal nanoimmunotherapy engages neutrophils to eliminate Staphylococcus aureus infections
J Zhu, R Xie, R Gao, Y Zhao, N Yodsanit, M Zhu, JC Burger, M Ye, Y Tong, ...
Nature Nanotechnology, 1-12, 2024
162024
Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathy
M Kabra, PK Shahi, Y Wang, D Sinha, A Spillane, GA Newby, S Saxena, ...
The Journal of Clinical Investigation 133 (19), 2023
92023
Targeted NAD+ Delivery for Intimal Hyperplasia and Re-endothelialization: A Novel Anti-restenotic Therapy Approach
L Yin, Y Tong, ZH Islam, K Zhang, R Xie, J Burger, N Hoyt, EW Kent, ...
bioRxiv, 2024.02. 20.581249, 2024
12024
Targeted NAD+ repletion via biomimetic nanoparticle enables simultaneous management of intimal hyperplasia and accelerated re-endothelialization: A proof-of-concept study …
L Yin, Y Tong, R Xie, Z Zhang, ZH Islam, K Zhang, J Burger, N Hoyt, ...
Journal of Controlled Release 376, 806-815, 2024
2024
Silica nanocapsules as a nonviral delivery platform for iPSC-RPE
D Sinha, Y Tong, MAF Zepeda, G Hanstad, EC Nelson, CO Theisen, ...
Investigative Ophthalmology & Visual Science 64 (8), 774-774, 2023
2023
Nonviral base editing of KCNJ13 mutation preserves vision in an inherited retinal channelopathy
M Kabra, PK Shahi, Y Wang, D Sinha, A Spillane, GA Newby, S Saxena, ...
bioRxiv, 2022.07. 12.499808, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–9